Found 6413 matches for
Largest genome-wide study of parasite provides clearest picture yet of genetic changes driving artemisinin resistance artemisinin-genetics-resistance. Hinxton, Cambridge, UK, 19 January 2015 – The largest genome-wide association study to date of the malaria parasite Plasmodium falciparum unveils a complex genetic architecture that enables the parasite to develop resistance to our most effective antimalarial drug, artemisinin.
Professor Nick White ells us about the COPCOV trial that aims to determine whether chloroquine or hydroxychloroquine are effective in preventing COVID-19 in health care workers.
Studentships at the Mahidol Oxford Tropical Medicine Research Unit in Bangkok, Thailand
COPCOV has more than doubled recruitment in the past month, with 1332 participants enrolled as of 7 July.